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Abstract 
Tissue banking (or biobanking), thought by many to be an essential form of medical research, has raised 
a number of ethical issues that highlight a need to understand the beliefs and values of tissue donors, 
including the motivations underlying consent or refusal to donate. Data from our qualitative study of the 
legal, social and ethical issues surrounding tumor banking in New South Wales, Australia, shows that 
participants’ attitudes to donation of tumor tissue for research are partially captured by theories of 
weak altruism and social exchange. However, we argue that the psychological rewards of value 
transformation described by Thompson’s rubbish theory provide additional insights into participants’ 
attitudes to tumor donation. We believe our data provides sufficient justification for an approach to 
regulation of tumor banking that is aimed at fostering a relationship based on the notions of virtuous 
reassignment and social exchange. 
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Stored collections of human tissue (“tissue banks” or “biobanks”), including collections of tumor 
samples, are thought by many scientists to be an essential resource for medical research (“tissue 
banking research”; Korn, 1996). In general terms, tissue removed from patients in the course of medical 
diagnosis or therapy is stored in tissue banks, and this tissue provides a means by which abnormalities in 
tissue can be correlated with disease aetiology, prognosis and treatment responsiveness.  
Tissue banking research has raised a number of challenging ethical issues particularly in response to 
a series of highly publicized “scandals” involving the non-consensual retention of human tissue and 
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organs in the United Kingdom and Australia, legal conflict over ownership of tissue used for the 
development of cell lines (e.g., Moore v the Regents of the University of California et al., discussed in 
Ashburn, Wilson, & Eisenstein, 2000), and growing sensitivity surrounding the use of DNA more 
generally. Areas of ethical concern include the means of obtaining consent for tissue banking, the 
management of donor privacy, including whether and to whom tissue-derived data can be disclosed, the 
ownership of tissue and the products of tissue-based research and whether tissue is “sacred” and 
therefore different to other types of health information (Campbell, 2000).  
The current regulatory complexity in many countries including Australia (Lipworth, 2005) reflects 
this growing dissonance. Tissue banks are commonly governed by numerous legislative and regulatory 
requirements as a result of which, the legal requirements regarding consent, access, privacy and 
ownership in relation to tissue frequently remain unclear. Unsurprisingly, a survey of tissue (in this case 
tumor) collection and research facilities in New South Wales revealed significant heterogeneity of 
methods for ensuring donor privacy and gaining consent, of levels of consent obtained and of 
information provided to donors (Clark, Lipworth, Bokey, Little, & Kerridge, 2006).  
Despite all of these issues, the rate of consent for the banking of tissue for research is generally 
high and has been demonstrated to remain so even in the wake of scandals (e.g., Seale et al., 2005). This 
places the onus on regulators and ethicists to ensure that people are donating their tissue for the right 
reasons and are not being exploited – particularly in instances in which donors are in a position of 
vulnerability. No better example exists of a potentially vulnerable tissue donor than a cancer patient 
asked to donate their excised tumor tissue for research. A patient undergoing tumor excision is not only 
in the midst of a traumatic experience, but is also highly dependent on the healthcare system and their 
interactions with clinicians, who might be the very people asking to bank their tumor tissue. Although 
the need to ensure protection of tissue donors has led to an explosion of research examining donor 
attitudes to tissue banking, only a few of these studies have specifically explored attitudes to tumor 
donation (Dixon-Woods, Wilson, Jackson, Cavers, & Pritchard-Jones, 2008; Kaphingst, Janoff, Harris, & 
Emmons, 2006).  
In an attempt to better understand the issues surrounding tumor banking, we conducted a 
qualitative study of lay perspectives regarding tumor donation for research with a view to answering the 
following broad research questions: 
1. What attitudes did participants express in relation to tumor donation for research? 
2. What might be the implications of these results for regulation of tumor banking? 
 
Materials and Methods 
This study was part of a multiple method study (Morse, 2009) of the legal, social and ethical issues 
surrounding tumor banking in New South Wales, Australia.  The aim of this research was to improve 
tumor banking processes in New South Wales through generation of empirically-grounded practical 
recommendations that are widely acceptable to researchers and consumers. Within this mixed methods 
study we conducted a series of qualitative interviews with a range of lay stakeholders, which we shall 
report here. 
Sampling and Recruitment 
This phase of the research involved interviews with patients (4) and parents of children (2) who had 
donated tissue to a tumor bank, health advocates (3), consumer representatives (2) and an indigenous 
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representative (1). Having received ethics approval from Sydney West Area Health Service, the 
University of Sydney and the appropriate hospital-specific ethics committees, we recruited lay 
participants by letter through one adult and one children’s hospital in Sydney’s western suburbs and a 
number of disease organizations and consumer groups. Recruitment ceased after thematic saturation 
had been reached.  
Participants included twelve men and women aged 35 to 86. Studies of this nature typically work 
with small numbers of informants and are based on detailed, in-depth interviews (i.e. they trade off the 
number of informants for a wealth of talk from each informant). Such studies do not aim to provide a 
single representative or average view or opinion, but are more concerned to account for the range of 
views, needs, values and beliefs of informants. Views expressed by participants in this study were highly 
consistent and thematic saturation was quickly reached.  
All participants identified themselves as Australian, although one included reference to Aboriginal 
descent and several to Anglo descent. Education levels of participants ranged from secondary-school to 
postgraduate level, although most had some tertiary education. Participants were asked to explain if 
and in what context they had previously encountered the idea of tumor banking. The initial degree of 
familiarity with the concept of tumor banking varied considerably among the participants, from those 
who were informed solely through media coverage, to those who had themselves banked tissue for 
treatment and/or research and had some knowledge of the issues involved. All participants were 
therefore given a brief introduction to tumor banking at the beginning of the interview to ensure that 
they had at least a basic understanding of the concept. 
Interviews were in-depth and semi-structured. Interviewees were asked a series of open-ended 
questions that allowed themes to emerge. Open-ended questions were followed by a series of prompts 
to explore the issues in greater depth. Interviews were transcribed and anonymized using randomly 
assigned numbers. All identifying information was stored in locked filing cabinets and password 
protected computers.  
Coding and analysis 
Analysis of the interviews was inductive and informed by Morse’s description of the generic cognitive 
underpinnings of qualitative research (Morse, 1994). After the interviews had been completed, 
members of the research team read the interviews and identified emergent themes. These themes were 
then abstracted into categories and concepts. Having examined the data in this manner we utilized 
abductive reasoning to identify a model of tumor donation that best fit the data. This is consistent with 
Peirce’s process of abduction (Peirce, 1958), recognized as part of the development process in 
qualitative analysis (Reichertz, 2007). 
 
Results 
Participants in our study overwhelmingly expressed their willingness to donate leftover tumor tissue for 
research because of “the good” that it might bring to others. One participant, for example, commented 
“I just always think that it’s always going to be used for the good.” These “others” included family, 
friends, disease community members (present and future), future generations, and at times simply 
“anyone”.  
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I think a lot of people will quite happily do it because it may not benefit them but people have got 
kids and things like that so there could be a benefit, not to them at this particular time but also to 
their family or friends and other people.  
 
Personal benefit, largely in the form of increased knowledge about one’s own health, was mentioned 
very occasionally as an added benefit of donating tissue, rather than the key motivating factor, as was 
an increased sense of agency.  
Being asked I thought was good in that it made me feel involved in it, and I was contributing 
something to research by being the mother of a daughter with cancer, I could say, “Yes, you can use 
this for research”, whereas everything else I was passive in a sense.  
 
When asked whether they would expect donors to receive a fee for their donation or a percentage of 
profits made, participants generally expressed that this was not only unnecessary but also undesirable. 
Frequently participants commented that they had not even considered the possibility that a profit might 
be made from their tissue when they agreed to donate. 
Although participants did not appear to expect any reward for tumor donation, many took the 
position of viewing donation as an act of reciprocity for years of research from which they had 
benefitted, or for the treatment they had received to date. 
I have a view of what comes around goes around, so I benefited from years of research and 
technology and medically and psychologically so I’m very much into pushing that back out again 
and making sure that I was given the benefit, I want someone else then to have that benefit as well.  
 
As such, tissue donation appeared to be viewed as part of a generalized or “indirect” form of reciprocity, 
in which the goodwill of others was reciprocated by the donor’s contribution and by which the act of 
donation contributes to the level of goodwill in the general community. Thus, the desire for tissue 
donation to benefit others and the community was an overriding theme.  
Although participants expressed a great willingness to donate, the circumstances of donation were 
constrained by the necessity to have tissue removed to preserve life and welfare. Some participants 
explicitly commented that because of the circumstances surrounding the request to donate, they did 
not have time to think about their decision to donate. However, they did not appear to see this as 
problematic. 
Interviewer (I): You mentioned that those days surrounding diagnosis and surgery were quite a blur, 
do you think it was appropriate for them to ask at that time or . . .  
Participant (P): Oh yes. 
I: . . . would you prefer if they’d waited til later? 
P: No, because when you’re going through it you’re thinking, “Well, that bit of research could be 
stopping somebody else down the track from having a problem.”  
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In most cases donation appeared to be a more or less automatic response to a suggestion made at the 
time of admission for surgery. For example, one participant, when asked “How did you feel about the 
idea of donating the tissue?” responded, “No worries. I just told them take whatever and do whatever.” 
Despite the circumstances under which donation took place, there was no sense of compulsion or 
manipulation, and interviewees were generally relaxed about their attitudes toward the uses to which 
their tissue might be put. Not only did participants express no sense of having or needing to be 
persuaded or coerced into donation, a few did not even appear to feel strongly about the need to be 
asked for permission to use their tissue. 
I: There’s been a lot of discussion about how to ask permission to store and use people’s tissue 
samples.  Do you think it’s necessary to ask for permission to use samples for research if they have 
already been taken for diagnosis? 
P: It wouldn’t have bothered me if they hadn’t asked. Personally it wouldn’t have bothered me, but I 
could imagine that some people would prefer to be asked.  
 
Participants frequently expressed that their tumor tissue was of no use to them and were somewhat 
puzzled that they needed to be asked for permission to use tissue that would only go to waste 
otherwise. 
I: Do you think that patients should be informed of whether it’s going to be kept, how long for, 
what’s going to be done with it? 
P: It wouldn’t have worried me, wouldn’t have cared, when you’re going through that process 
there’s bigger things that fill your mind and this little bit of tissue, who cares, I would have imagined 
they would have kept the slide, whatever tissue existed on that slide and everything else thrown 
away, so that slide is sitting somewhere for future reference, like evidence in a murder case or 
something is just kept there. I would have thought that, but if they had have asked me “Can we 
keep this for twenty years”, I probably would have said, “Why? It’s bad! No throw it out, don’t want 
it!” I was very happy for it to be out of me.  
 
It was mentioned only occasionally that donors would be “giving up” part of their body. One participant 
commented that “to them it’s part of their body, it’s something that’s been taken away from them.”. 
These comments were largely made by an Aboriginal liaison officer who was interviewed, highlighting 
the role that culture and ethnicity might play in such issues.  
Overwhelmingly participants demonstrated a pervasive lack of concern, at times bordering on total 
indifference, when asked about donation of tissue for research. They commented that it was “a lot of 
fuss about nothing”, that “it wouldn’t really matter”, they had “no worries”, “no hesitations” and “no 
problems”, and even that they “really didn’t care”.  
To ensure that this lack of concern was not because of a lack of awareness of the potential risks 
involved in tumor banking the interviewer introduced a series of examples, in the form of hypothetical 
scenarios, throughout the interview. However, the participants’ lack of concern generally held firm. 
I: Obviously one of the types of information that scientists can get from your tissue is to do with 
genetics as you mentioned before. So by looking at the genes in cells we can tell a lot of information 
about what you’ve inherited from your parents and what you might pass on to your children and 
 6 
also what might happen with your health in the future, so would you have any concerns about that 
genetic information being contained in the tissue and made available to researchers?             
P: No I don’t have any concerns.  
 
I: So there’s a lot of different types of research that can be done on tissue, for example a researcher 
might want to look at whether people with a particular gene are more likely to get a certain 
disease, or whether people with different types of disease respond better to treatment. Sometimes 
tissue is collected for a specific research project but then once that project and those particular 
questions are finished and answered another researcher might want to use it for a totally different 
research project. So how would you feel if you’d given permission, for your tissue to be used for a 
particular project and then someone else wanted to use it for something different? 
P: No problem. 
I: Would you want them to ask you? 
P: No. Quite happy.  
 
It appeared that participants were aware of possible risks but were not concerned about those risks 
themselves. This was demonstrated by their ability to acknowledge that other people might have 
concerns about certain issues although they themselves did not. 
In the few instances where participants did express concern about the possibility of future risk they 
responded in several different ways. Some issues, such as possible private company involvement and 
third-party access worried a couple of participants but did not appear to jeopardize their willingness to 
donate. For example, one participant commented, “I can see there will be slip-ups, there’ll be people 
who do the wrong thing for profit, I think it’s a risk you’ve got to run.” Where willingness to participate 
did waver, this seemed to be associated with fears about the potential use of their tissue for embryonic 
stem cell research or reproductive cloning. However, in general there seemed to be a strong belief that 
risks, though concerning, were not in fact substantive. Possibilities such as cloning were considered 
“science fictiony” examples of “weird research” that were highly unlikely to eventuate in reality. 
But I could not imagine them cloning, I think that might have even crossed my mind at the time, and 
I just thought no one is going to clone something from a tumor cell that I can imagine.  
 
Summary 
Analysis of the empirical data in this study therefore indicates that donors had a high level of willingness 
to donate tumor tissue for research. Donation was often considered to be “no big deal”, given that it 
involved the use of tissue which would be discarded anyway and was perceived as involving little or no 
credible risk. At times donation appeared to be nothing more than an automatic response or 
afterthought made by an individual facing more urgent and threatening health concerns. Despite the 
sense that tumor donation was “a lot of fuss about nothing” donors expressed considerable satisfaction 
at the thought that their donation might benefit others and contribute to a generalized system of 
reciprocity.  
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Discussion 
How do our results relate to models of tissue donation previously discussed in the literature? Perhaps 
owing to Titmuss’s celebrated concept of the gift relationship in blood donation (Titmuss, 1970), the 
majority of empirical studies regarding tissue donation focus on altruism (Barr, 2006; Boe & Ponder, 
1981; Hoeyer, 2003; Hoeyer & Lynoe, 2006; Kettis-Lindlblad, Ring, Viberth, & Hansson, 2005; Medical 
Research Council & the Wellcome Trust, 2000; Medical Research Council & the Wellcome Trust, 2002; 
Zaller, et al., 2005; ) and social exchange (Barr, 2006; Dixon-Woods et al., 2008; Lipworth, 2005; 
Ormond, Cirino, Helenowski, Chisholm, & Wolf, 2009) as models of tissue donation. As mentioned 
above, few researchers have reported exploring the ways in which attitudes to donation of tumor tissue 
might differ from that of other tissues. Definitions of altruism and social exchange resonated with many 
of our results. We found, however, that neither of these theories adequately explained the nuances of 
participants’ responses. 
Altruism 
The precise definition of altruism has been heavily debated by scholars in numerous fields including 
economics, psychology, evolutionary biology and sociology. In the context of tissue donation for both 
research and therapeutic purposes, altruism has been variously interpreted  as the desire to help a 
stranger (Hantchef, 1963), service to the community (Phillips, 1961), recognition of a need to help 
others (Boskovic, 1964; Hocking et al., 1974) and benefit future patients (Kettis-Lindblad et al., 2005), 
having a sense of duty, a belief that it is the right thing to do or that it is a worthy cause (American 
National Red Cross, 1964; Hemphill, 1969; Medical Research Council & the Wellcome Trust, 2002), 
gratitude (Boe & Timmens, 1966) and humanitarian interests (London & Hemphill, 1965; Oswalt & 
Napoliello, 1974). The variable and often atheoretical manner in which altruism is defined (or not 
defined) in these studies, has resulted in a lack of clarity regarding the significance and implications of 
their findings. 
A definition of altruism put forward by Simmons, which is drawn from a comprehensive review of 
the altruism literature and includes four characteristics common to many writers and consistent with 
her own research requires that altruism (a) seeks to increase another’s welfare, not one’s own; (b) is 
voluntary; (c) is intentional; and (d) expects no reward (Simmons, 1991). Many of the elements 
contained in these definitions of altruism were present in our data. Donors spontaneously expressed 
concern that their donations should benefit others. They were firm in stating that their donations were 
voluntary and uncoerced. Mention of benefit resulting from donation was made in reference to others 
rather than themselves. 
However, participants did not perceive that they would be assuming a cost through the act of 
donation. Perceptions of “risk” and therefore potential self-sacrifice are not essential to establish the 
presence of altruism, but they do provide some measure of its intensity (Monroe, 2004). Monroe, for 
example, has argued that altruism must include willingness to assume cost (in the form of risk or 
sacrifice). The necessity for altruism to include risk or sacrifice has been heavily debated. This issue is 
particularly relevant in the case of donation of left-over surgical waste, such as tumor tissue, which 
requires no further action on the part of the participant and no additional procedure and which, as we 
have seen, is generally not seen by donors as placing them at risk of future harm . It has been previously 
suggested that altruism is influenced by the ease of donation (Haimes & Whong-Barr, 2004) and that 
decision-making and consent in the case of donation of surgical waste is perceived as easier and of less 
importance by donors (Medical Research Council & the Wellcome Trust, 2000). Indeed, fear of injury, 
fear of after-effects, fear of pain and needles, time and inconvenience–the dominant reasons reported 
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for non-donation of healthy tissue (Boe & Ponder, 1981)–are largely irrelevant in the case of tumor 
donation.  
Intentionality in the context of tumor donation is also problematic given the compelling 
circumstances that led to the removal of tumor tissue i.e. the necessity to preserve life and welfare of 
the patient. Although the satisfaction that donors appeared to draw from the sense that they were 
contributing to “the good” resonates with theories of altruism, intentionality was neither strongly nor 
spontaneously expressed. Participants did not express a pre-existing desire to do good by contributing 
to research, that was subsequently fulfilled by a request to donate tissue. Rather, donation appeared to 
be a more or less automatic response to a specific request to donate tissue, made in the context of 
ridding themselves of something that was unwanted and would be thrown away anyway. The intention 
to benefit others consequently appeared to emerge as part of a post-hoc rationalization or 
“reconstructed logic”–a reflective recognition or explanation for the satisfaction of feeling involved. 
Although some more inclusive definitions of altruism might allow for the inclusion of acts which do 
not involve cost to the donor and which involve only weak intentionality, it is certainly the case that 
many stronger definitions of altruism would exclude such acts. We would therefore argue that the 
attitudes expressed by participants in our study could, at most, be characterized as “weak altruism” 
(Dahl, 1980; Hornstein, 1976; Monroe, 2004; Simmons, 1991).  
Social exchange 
In the sense that participants saw tumor donation as an act of reciprocation, tumor donation might be 
considered a form of social exchange. Donations were frequently viewed as reciprocating the 
contributions of citizens in the past, as well as contributing to treatment of future patients. Our data 
indicates that this system of exchange involves weak, indirect reciprocity between groups rather than 
individuals, as described by Levi-Strauss (Levi-Strauss, 1949). This is not the first time that donors have 
been identified as having a sense of contributing to a collective of others who have contributed to 
previous research and thereby engaging in a form of indirect, non-monetary exchange (Dixon-Woods, 
Wilson, Jackson, Cavers, & Pritchard-Jones, 2008; Felt, Bister, Strassnig, & Wagner, 2009; Svendsen, 
2007).  
However, social exchange theory is based on the notion that one gives up something of enduring 
social and symbolic value (Ekeh, 1994). Participants in this study frequently made comments that 
suggest that their tumor tissue held low intrinsic value for them. Their tissue was “useless”, “waste” and 
was intended to be “thrown away”. This is not necessarily inconsistent with social exchange. Waldby 
(2002), for example, has pointed to the potential for tissues to be imbued with differing value, 
depending on their position in a social network of tissue exchange. However, social exchange theory 
alone does not appear to provide a complete explanation of participants’ attitudes to tumor donation. 
In particular, we recognized that tumor tissue appeared to gain a new status (changing from something 
of no value to something of value) through the act of donation, and we wished to understand the 
process by which waste material might come to have value within a system of social exchange. This 
process of revalorization led us to consider a lesser known theory which incorporates elements of both 
altruism and social exchange theory and which appears to better capture the nuances of our results 
than either of these theories in isolation. 
Rubbish theory 
Cultural theorist Michael Thompson classified the “things” that people have in their lives as falling into 
three socially defined categories (Thompson, 1979).  
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1. Durable items have lasting value that either holds or increases over time, for example, a 
Monet painting (Thompson, 1979, p. 7). Durable items are widely valued financially, 
emotionally and cognitively in a relatively stable way. They are awarded a social status that 
determines appropriate social and individual actions such as preservation, protection and 
regulated sale.  
2. Items in a state of flux are those whose value shifts around (Thompson, 1979, p. 8). Values in 
this category are dependent on social actions and choices, such as what collectors determine 
the desirability of a new artist’s work to be. Items in flux might at length graduate to become 
durable items or they might be relegated to the third category.  
3. Transient items represent things with falling or fallen value, such as second hand computers 
(Thompson, 1979, p. 7). As with durable items they have a stable social status that determines 
social and individual actions such as removing and remaindering.  
 
Thompson (1979) points out that durable and transient items have achieved stable social status at 
opposite ends of a scale of approval. It is the items in flux that still carry the possibility of “innovation 
and creativity”. But he also stresses that there is another category of objects that continue to exist “in a 
timeless and valueless limbo where at some later date it has the chance to be rediscovered” (Thompson, 
1979, p. 10). This category is rubbish. Rubbish might be valueless at the time it is socially defined, but 
yesterday’s rubbish might become today’s archaeological treasures. Time and social interest can turn 
rubbish into durable objects of value. 
Thompson makes a special case of body products. There is “waste material” (feces or urine), which 
is rapidly construed as rubbish (as distinct from durable material, such as body parts). In between are 
body products, such as milk and tears, which may be subject to social revision of values. Tumor tissue is 
a particularly interesting example of a body product. It is, in a sense, rubbish, to be discarded at all costs, 
and donors in this study frequently make the point that the tissue they are being asked to donate is 
“useless” to them and would be “thrown away” or “go to waste” otherwise. However, in recent years, 
tumor tissue has had a “social status-promotion” as a source of medical wisdom, an object of study, a 
way toward future benefits for “mankind” (Janin, 2004). As such, the status of a piece of tumor tissue 
may be redeemed and transferred to something durable. Of course, unlike a masterpiece that has been 
rediscovered, tumor tissue only has value in a particular context (an issue not explicitly dealt with by 
Thompson). Nonetheless, the notion of revalorized rubbish does have particular explanatory power in 
the context of our study. 
In light of rubbish theory we would argue that donors retrospectively construct the meanings of 
their donations from three perspectives–weak altruism, social exchange and revalorization of rubbish:  
they have a desire to contribute to the creation of a good society through the benefits which will accrue 
to the public as a result of the reconstrual of their “hostile waste” as something beneficial to others, 
something that has status as a medium of social exchange. The addition of the notion of category 
reassignment to existing models of altruism and social exchange more adequately explains the 
ambiguity and weakness of intentionality apparent in our interviews, the sense that the desire to benefit 
others was more of an afterthought than a clear intention, as well as the lack of concern, bordering on 
un-interestedness surrounding the use of a piece of tissue that donors were anxious to be rid of. 
Furthermore, rubbish theory helps to explain the retrospective sense of satisfaction that participants 
gained from the act of donating that which would have been disposed of anyway. To have the tumour 
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tissue donation reconstrued as something positive, is to have the status of a piece of rubbish redeemed 
and transferred to the status of something durable. In our study, patients referred to this 
transformation with appreciation. Their rubbish had become someone else’s potential for prevention or 
healing. To be a donor is to be reconstrued socially as a benefactor, a source of something durable and 
valuable rather than of something transient and horrible.  
Unfortunately, rubbish theory has fallen into some disrepute (Benthall, 1979; Culler, 1985; Fararo, 
1981; Goodin, 1981; Smith 1980). Thompsons’s original work has been criticised for his move from the 
qualitative domains of sociology and anthropology to the quantitative domain of catastrophe theory 
(Thom, 1975). His projected topological models fail to convince his critics completely, however much 
they have been persuaded by his detailed description and explanation of value assignment and its 
revisions. However, for all its weaknesses in Thompson’s formulation, his sociological and 
anthropological theorizing does provide a way enrich our understanding of the mechanisms and 
psychological implications of tumor donation.  
 
Implications 
If indeed rubbish theory is an appropriate model for tumor donation, there should be important 
psychological consequences for the ways in which donors perceive the value of their donations (Geyer-
Ryan, 1992). Geyer-Ryan links rubbish and its redemption into something of value to psychological 
responses: 
In everyday life the psychic position of the abject is fused with a social value system of purity and 
filth. Under ultimately contingent circumstances, objects normally categorized as rubbish can be 
elevated into positivity, and are thus “sublimated” into a collector’s item, for example, or any other 
value of distinction. The zero-position of garbage within the realm of real and symbolic objects is 
analogous to the position of the abject in the psychic domain (p. 503). 
 
Alienation of the body in illness is a familiar theme of the illness experience literature (Frank, 1995; 
Frank, 1998; Hyden, 1997; McKenzie & Crouch, 2004; Mechanic & Meyer, 2000; Taylor, 1983; Toombs, 
1992) and it has been linked to the stigma attached to specific illnesses such as acquired 
immunodeficiency syndrome (AIDS) and cancer (Fife & Wright, 2000). Abjection has been explicitly 
linked to the cancer experience (Waskul & Riet, 2002) and its positive reconceptualization to 
posttraumatic growth (Joseph & Linley, 2008). Donors of tumor tissue in the present study experienced 
the elevation of their tumor tissue’s status from private and rubbish, to social and virtuous–the tissue 
and the act of handing it over have undergone revalorization. The process of revalorization offers at 
least some confirmation that the whole challenging and disruptive episode can have a larger 
epistemological and moral meaning. As a result, tumor donation might reinforce the process of 
posttraumatic growth, thus contributing to the restoration of the patient’s identity and sense of 
inclusion in society.  
This model of tumor donation might also have implications for the legal, social and ethical 
management of tumor banking and research. To begin with, it appears that some of the key concerns 
that have been widely discussed in relation to organ donation for therapeutic purposes are less relevant 
in the context of donation of surgical waste for tissue research. Unlike therapeutic donation, the 
problem of increasing donation rates is not an issue in this context. Consent for tissue donation is very 
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high and our participants expressed an almost unfailing willingness to donate their tissue. The issue is 
one of opportunity rather than of influence.  
Indeed, in light of the insights gained from rubbish theory, ensuring that cancer patients are given 
every opportunity to donate discarded tissue whenever possible may be a moral imperative. The 
opportunity to donate provides cancer patients with the prospect of feeling that they are contributing to 
and thus maintaining the creative possibility of converting potential rubbish into something of enduring 
worth, thereby contributing to the possibility of posttraumatic growth. Ongoing communication 
between tumor banking institutions and donors, might further enhance the opportunity for 
posttraumatic growth by allowing donors to see the benefits that result from their donation. We would 
argue for such things as websites and public meetings to inform those who are interested, and the 
inclusion of interested members of the public on tissue bank advisory committees as suggested 
previously by Ashburn and colleagues (Ashburn et al., 2000).  
Finally, if we consider that donors of surgical waste are motivated by the redemptive ideal that 
their “hostile waste” can be reconstrued as something beneficial to society and that their donation can 
become part of a general, reciprocal system of good citizenship, then it is vital that this system of re-
valorization be maintained. It is probably no coincidence that our findings emerged in the context of the 
Australian health system in which there is universal health coverage under a national tax-based scheme. 
The participants in our study believed that benefits provided in exchange for the donation of 
“disposable” tissue would be distributed to society generally, rather than to individual donors. However, 
if the nature of the healthcare system and thus the system of exchange or reassignment between 
biomedical science and the public were to change, so would the approach to tumor banking regulation. 
Given that there are already complex relationships between commerce and academic biomedicine, 
tissue banks would need to be clear who could use donated tissue and for what purpose, as such 
information might change the nature of public attitudes to donation. 
Finally, if we consider that donors of surgical waste are motivated by the redemptive ideal that 
their “hostile waste” can be reconstrued as something beneficial to society and that their donation can 
become part of a general, reciprocal system of good citizenship, then it is vital that this system of re-
valorization be maintained. It is probably no coincidence that our findings emerged in the context of the 
Australian health system in which there is universal health coverage under a national tax-based scheme. 
The participants in our study believed that benefits provided in exchange for the donation of 
“disposable” tissue would be distributed to society generally, rather than to individual donors. However, 
if the nature of the healthcare system and thus the system of exchange or reassignment between 
biomedical science and the public were to change, so would the approach to tumor banking regulation. 
Given that there are already complex relationships between commerce and academic biomedicine, 
tissue banks would need to be clear who could use donated tissue and for what purpose, as such 
information might change the nature of public attitudes to donation. 
There are a number of important limitations to this study. Being a qualitative study, it is based on a 
detailed analysis of interviews with a small number of participants, and in the absence of confirmatory 
studies that use more representative (i.e. more random) methods of sampling, the findings should not 
be generalised to any wider population. Although other studies do exist which have explored the status 
of tissue (Barr, 2006; Dixon-Woods et al., 2008; Gustafsson Stolta, Lissb, Svenssonc, & Ludvigsson, 2002; 
Hoeyer, 2006), they are scarce and have not utilised a rubbish theory framework of analysis. Our study, 
and others examining the status of tissue, was also conducted in a western (or westernised) population, 
and tissue is likely to have different significance in other settings. Indeed, the process of revalorisation 
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we have proposed might be meaningless in a context in which tissue always has profound status. We 
therefore present our findings as hypotheses that need to be replicated by studies conducted in other 
settings and in relation to other tissue types.   
 
Conclusion 
In this article we have argued, based on empirical data, that lay attitudes to donation of tumor tissue for 
research in New South Wales, Australia, are more adequately captured by rubbish theory, than by 
theories of altruism and social exchange alone. We believe that our data provides sufficient justification 
for an approach to regulation of tumor banking that is aimed at fostering a relationship based on the 
notion of virtuous reassignment and social exchange. We have suggested that this relationship can be 
maintained and encouraged by ensuring that tumor banking research continues to benefit the public 
and by ensuring that cancer patients are given every opportunity to donate their tumor tissue to 
research and thus to facilitate their posttraumatic growth. We believe that this approach is not only 
consistent with the values of tumor donors but will serve to promote progress in research. 
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